Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
200 participants
OBSERVATIONAL
2015-06-30
2016-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
SEEQ™ MCT/ECM System
SEEQ™ MCT/ECM monitoring for the detection of non-lethal cardiac arrhythmias.
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patient is 18 years of age or older
* Patient is willing and able to provide consent and authorize the use and disclosure of health information
* Patient is willing and able to comply with the protocol
Exclusion Criteria
* Patient has suspected potential life-threatening arrhythmias, or requires in-subject/in-hospital monitoring.
* Patient will undergo a medical procedure that would preclude full participate during the prescribed duration of the SEEQ™
* Patient has an implanted cardiac device, (e.g., pacemaker, Implantable Cardioverter Defibrillator, Cardiac Resynchronization Therapy)
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Medtronic Cardiac Rhythm and Heart Failure
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
SEEQ Performance Study Clinical Team
Role: STUDY_DIRECTOR
Medtronic
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Larkspur, California, United States
Simi Valley, California, United States
Aurora, Colorado, United States
Clearwater, Florida, United States
Palm Beach Gardens, Florida, United States
Sebring, Florida, United States
Rome, Georgia, United States
Jackson, Mississippi, United States
Henderson, Nevada, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
SEEQ™ Performance Study
Identifier Type: -
Identifier Source: org_study_id